American Society of Hematology, Blood, 20(127), p. 2451-2459, 2016
DOI: 10.1182/blood-2015-12-688705
Full text: Download
Key Points Recurrent mutations in chromatin modifiers and cohesin were observed in t(8;21) AML, but not inv(16) AML. t(8;21) AML patients with mutations in kinase signaling plus chromatin modifiers or cohesin members had the highest risk of relapse.